Skip to main content
. 2020 Mar 6;25(3):e416–e424. doi: 10.4317/medoral.23461

Figure 1.

Figure 1

(A) Overall survival (OS) for the three age groups (p= 0.9). (B) Disease-specific survival (DSS) for the three age groups (p= 0.6). (C) Disease-specific survival (DSS) of young patients according to clinical stage (p= 0.02). (D) Disease specific survival (DSS) for oral and oropharyngeal squamous cell carcinoma in the young patients (p= 0.7).